Gut-Directed Hypnotherapy in 2025
What the Science Actually Says
By Angela Vincent | Natural State Hypnosis Clinical Hypnotherapist | RN Background | Hobart & Telehealth
If you've been told that hypnotherapy for gut disorders is "alternative medicine," the research published in the last 12 months has something important to say about that.
Gut-directed hypnotherapy (GDH) is now one of the two most evidence-based brain-gut behavioural therapies available for Irritable Bowel Syndrome and related functional gut disorders, sitting alongside Cognitive Behavioural Therapy (CBT) as a recommended second-line treatment in both European and North American gastroenterology guidelines. Not fringe. Not anecdotal. Guideline-recommended.
As a practitioner with an RN background and specialist experience in complex clinical care, I've watched this field evolve significantly. What excites me most right now is that the research is no longer just asking does it work, it's asking how it works, and the answers coming from neuroimaging are genuinely remarkable.
Here's what the current science tells us.
The landmark 2025 meta-analysis
In April 2025, a systematic review and meta-analysis published in Neurogastroenterology & Motility (Adler et al., 2025) analysed 12 studies involving 1,158 IBS patients, the most comprehensive analysis of gut-directed hypnotherapy to date.
The findings were clear:
Every single one of the 12 studies found GDH to be superior to the comparator treatment
Nine of the twelve were statistically significant
GDH significantly improved pain symptoms compared to standard IBS interventions
Group-delivered GDH showed statistically significant improvement in global IBS symptoms
This is not a small pilot study. This is over a thousand patients, across multiple trial designs, all pointing in the same direction.
What fMRI is showing us: the brain really does change
Perhaps the most compelling development in this field is what functional MRI (fMRI) imaging has revealed about why gut-directed hypnotherapy works.
A study by Lowén and colleagues demonstrated that hypnotherapy produces measurable changes in brain activity in regions associated with pain processing and digestive regulation. In other words, GDH doesn't just change how people feel about their symptoms, it changes the neurological patterns driving them.
This matters clinically. IBS and functional gut disorders are now well understood as disorders of the gut-brain axis. Conditions where the communication pathway between the enteric nervous system and the central nervous system becomes dysregulated. The gut has its own nervous system containing more neurons than the spinal cord, and in IBS, that system is in a state of chronic hypersensitivity.
GDH works by directly targeting that hypersensitivity at the neurological level, calming the overactive signalling patterns between the brain and gut that perpetuate symptoms. The fMRI data gives us a window into that process, and what it shows is genuine neurological change, not placebo.
Long-term outcomes: this is not short-term relief
One of the most clinically significant findings in the GDH literature is the durability of outcomes.
In a foundational long-term study, 81% of patients who responded to gut-directed hypnotherapy reported that their improvements were maintained or continued to improve, for up to five years after completing treatment. This stands in contrast to many pharmacological treatments where symptom return after cessation is common.
More recently, research has confirmed that:
Benefits are sustained at 12-month follow-up in multiple studies
Patients who complete a full GDH program often report reduced need for ongoing medication
Quality of life improvements: including psychological wellbeing, reduced anxiety and increased resilience persists well beyond the treatment period
Comparable to the low FODMAP diet and combinable with it
A randomised clinical trial published in the American Journal of Gastroenterology found that gut-directed hypnotherapy produced outcomes comparable to the low FODMAP diet, one of the most widely recommended dietary interventions for IBS.
This is significant for two reasons. First, it positions GDH as a legitimate first-tier adjunct rather than a last resort. Second, it suggests that for patients who find the low FODMAP diet restrictive, difficult to sustain, or socially isolating, GDH offers an equally effective alternative pathway.
In clinical practice, the two approaches can also be combined, addressing both the physiological and neurological dimensions of gut dysfunction simultaneously.
Digital and group delivery: access is expanding
A 2025 digital therapeutics review confirmed that GDH is among the most evidence-based brain-gut behavioural therapies,and importantly, recent trials have validated delivery formats beyond traditional one-to-one sessions.
A randomised controlled trial of digital GDH (the Regulora app) found that self-administered digital hypnotherapy produced clinically meaningful improvements in abdominal pain and stool symptoms with no serious adverse events. Nurse-administered group GDH programs in Sweden have also shown strong outcomes across large patient cohorts with follow-up data collected at 6 months, 1 year and 2 years post-treatment.
This means the barrier of geographic access, long a limitation for patients in regional and rural areas is being actively addressed. Online and Telehealth delivery of GDH is not a compromise. It is evidence-supported.
Who is gut-directed hypnotherapy for?
Based on the current evidence, GDH is appropriate as an adjunct or standalone intervention for:
Adults and children with:
Irritable Bowel Syndrome (IBS) all subtypes
Functional gut disorders and abdominal pain syndromes
Functional dyspepsia
Gut symptoms associated with anxiety or chronic stress
Pelvic pain syndromes with a gut-brain axis component
Gut symptoms refractory to standard medical treatment
It is not a replacement for medical investigation and diagnosis. A formal diagnosis from a gastroenterologist or GP is the appropriate starting point, GDH sits within the treatment plan, not instead of it.
What a course of treatment looks like
At Natural State Hypnosis, gut-directed hypnotherapy programs are structured across 6–10 sessions, consistent with the protocols used in the major clinical trials. Each session builds on the last, progressively deepening the neurological regulation of the gut-brain connection.
Sessions are available in-person in Hobart and via telehealth nationally. For GP and specialist referrals, a written clinical summary is returned to the referring clinician on completion of the program.
A note on the evidence base. Honest and Balanced
No therapy has a 100% response rate, and gut-directed hypnotherapy is no exception. Response rates in clinical studies range from 24% to 73% depending on patient population, delivery format, and outcome measures, a wide range that reflects the heterogeneity of IBS itself rather than inconsistency in the therapy.
What the research consistently shows is that for those who do respond, the benefits are meaningful, durable, and extend well beyond gut symptoms into overall quality of life. And critically, GDH has an excellent safety profile. No serious adverse events have been reported across major clinical trials.
The bottom line
Gut-directed hypnotherapy has moved well beyond the realm of "promising but unproven." The 2025 evidence base including a meta-analysis of over 1,000 patients, fMRI neuro-imaging data, long-term follow-up studies, and guideline endorsements from major gastroenterology bodies, positions GDH as a legitimate, effective, and durable treatment option for functional gut disorders.
For patients who have tried dietary modifications, medications, and standard management without lasting relief, it may represent the missing piece of their treatment puzzle.
Angela Vincent is a clinical hypnotherapist with an RN background and specialist experience in oncology and clinical education. She practises at Natural State Hypnosis in Hobart, Tasmania, offering in-person and telehealth services nationally.
For GP and specialist referral information, visit the For Clinicians page.
To make an appointment or enquiry, visit naturalstatehypnosis.com or book via Halaxy.
References
Adler, E.C., Levine, E.H., Ibarra, A.N., et al. (2025). Gut-directed hypnotherapy for irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterology & Motility, 37(7), e70037. https://doi.org/10.1111/nmo.70037
Häuser, W. (2024). Gut-directed hypnosis and hypnotherapy for irritable bowel syndrome: a mini-review. Frontiers in Psychology, 15, 1389911. https://doi.org/10.3389/fpsyg.2024.1389911
Lowén, M.B.O., et al. (2018). Effect of hypnotherapy and educational intervention on brain response to visceral stimulus perception in the irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. https://onlinelibrary.wiley.com/
Peters, S.L., et al. Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. American Journal of Gastroenterology.
Frontiers in Gastroenterology (2025). A multidisciplinary approach to the management of disorders of gut-brain interaction: psychopharmacology, psychotherapy, and diet. https://doi.org/10.3389/fgstr.2025.1637172
Gastroenterology & Hepatology (May 2025). The promise of digital therapeutics for disorders of gut-brain interaction. https://www.gastroenterologyandhepatology.net/archives/may-2025/
Wong, R.K., et al. (2020). Hypnosis and functional gut disorders. Australian Journal of Clinical Hypnotherapy and Hypnosis / AH